AZD-9291 |
AZD-9291 FREE BASE |
OSIMERTINIB |
TAGRISSO |
AZD9291 |
TAGRISSO® |
MERELETINIB (OBSOLETE INN) |
N-(2-{[2-(DIMETHYLAMINO)ETHYL](METHYL)AMINO}-4-METHOXY-5-{[4-(1-METHYL-1H-INDOL-3-YL)PYRIMIDIN-2-YL]AMINO}PHENYL)PROP-2-ENAMIDE |
MERELETINIB |
AZD 9291 |
chembl:CHEMBL3353410 |
drugbank:09330 |
pubchem.compound:71496458 |
chemidplus:1421373-65-0 |
rxcui:1721560 |
Drug Categories | acrylates |
FDA Approval | Non-small cell lung cancer (with EGFR T790M mutation) |
Drug Class | Kinase Inhibitor |
Drug Categories | antineoplastic and immunomodulating agents |
Drug Categories | breast cancer resistance protein inhibitors |
Drug Categories | cytochrome p-450 cyp1a2 inducers (strength unknown) |
Drug Categories | cytochrome p-450 cyp3a inhibitors |
Drug Categories | cytochrome p-450 cyp3a substrates |
Drug Categories | cytochrome p-450 cyp3a4 inducers |
Drug Categories | cytochrome p-450 cyp3a4 inducers (strength unknown) |
Drug Categories | cytochrome p-450 cyp3a4 inhibitors |
Drug Categories | cytochrome p-450 cyp3a4 inhibitors (weak) |
Drug Categories | cytochrome p-450 cyp3a4 substrates |
Drug Categories | cytochrome p-450 cyp3a4 substrates (strength unknown) |
Drug Categories | cytochrome p-450 enzyme inducers |
Drug Categories | cytochrome p-450 enzyme inhibitors |
Drug Categories | cytochrome p-450 substrates |
Drug Categories | kinase inhibitor |
Drug Categories | narrow therapeutic index drugs |
Drug Categories | p-glycoprotein substrates |
Drug Categories | tyrosine kinase inhibitors |
inhibitor (inhibitory) |
Specific Action of the Ligand | Inhibition |
Endogenous Drug? | False |
Direct Interaction? | False |
OSIMERTINIB | DrugBank Drug Name |
1421373-65-0 | CAS Number |
Tagrisso | Drug Brand |
Drug Type | small molecule |
Drug Groups | approved |
Drug Categories | acids, acyclic |
TAGRISSO | Trade Name |
Drug Class | Kinase Inhibitor |
FDA Approval | Non-small cell lung cancer (with EGFR T790M mutation) |
OSIMERTINIB | GuideToPharmacology Ligand Name |
D0RT2C | TTD Drug ID |